Navigation Links
Sunrise Pharmaceutical, Inc. Sued for Violation of New Jersey Consumer Fraud Act
Date:9/17/2013

ESTERO, Fla., Sept. 17, 2013 /PRNewswire/ -- Vision Pharma, LLC has initiated a civil action against Sunrise Pharmaceutical, Inc. of Rahway, New Jersey in U.S. District Court for the District of New Jersey, Trenton Division. The nine-count lawsuit seeks to recover at least $3 million from Sunrise Pharmaceutical, plus statute-imposed, mandatory treble damages and attorney fees pursuant to NJ Stat. Ann. § 56:8-19, stemming from Sunrise Pharmaceutical's defective manufacture of certain drug products deemed adulterated and unsalable by the U.S. Food & Drug Administration (FDA) as well as Sunrise Pharmaceutical's willful sale of said adulterated drugs to Vision Pharma without notice of the FDA's investigations and determinations.  The case is styled Vision Pharma, LLC v. Sunrise Pharmaceutical Inc., C.A. No. 2:13-cv-04692-CCC-JAD and is now pending before the Hon. Claire C. Cecchi.

A full list of the nine (9) causes of action asserted by Vision Pharma upon which it seeks relief from the U.S. District Court is as follows:

Count 1:  Violation of New Jersey Consumer Fraud Act
Count 2:  Breach of Contract
Count 3:  Willful Breach of Implied Warranty of Merchantability
Count 4:  Breach of Implied Warranty of Fitness for a Particular Purpose
Count 5:  Breach of Covenant of Good Faith and Fair Dealing
Count 6:  Unjust Enrichment
Count 7:  Negligence
Count 8:  Deceptive Trade Practices
Count 9:  Fraud & Deceit

"It is very unfortunate that we had to file suit against Sunrise Pharmaceutical after numerous attempts to resolve these issues amicably; however, the severe damage they caused our company left this as the only option.  We are certainly prepared for a trial by jury and taking this case to the end for a well-deserved victory," said Sander S. Busman, Founder, President & CEO, Vision Pharma.  Vision Pharma is being represented by lead counsel Cameron S. Reuber, Esq. and a team of attorneys at Leason Ellis LLP.

About Vision Pharma
Vision Pharma specializes in niche, generic pharmaceuticals with various delivery options and dosage forms. The company provides quality products at competitive prices while improving the lives of those who take their medicines. The organization's customer service acts promptly to requests while continuously improving to fulfill each customer and patient need. Maintaining additional inventory ensures Vision's ability to provide increased service levels. The pipeline of generic pharmaceuticals planned to market continues to be a strong focus internally and with other pharmaceutical organizations, domestically and internationally. Valuable relationships that are built show true dedication to each partnering company. You can count on Vision Pharma to consider the patient's safety as a top priority when developing and manufacturing their items. To learn more, please visit www.visionpharma.com.

Media Relations Contact:
Sander S. Busman                                                                  
Vision Pharma
Founder, President & CEO
sbusman@visionpharma.com

 


'/>"/>
SOURCE Vision Pharma
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Healthcare Briefing - Leading Medical Companies in the News: Bio-Solutions, Catalyst Pharmaceutical, MannKind, Amgen, Accuray
2. New Air Products Microsite Features Advanced Liquid Nitrogen Solutions for the Chemical, Pharmaceutical, and Life Science Industries
3. Bernstein Liebhard LLP Announces That A Securities Class Action Has Been Filed Against Aveo Pharmaceutical, Inc.
4. Earnings Forecast Stock Alerts: American International Group, Teva Pharmaceutical, CSX, Exxon Mobil, Lowes, and Seagate
5. CorePharma Addresses Violations in FDA Warning Letter
6. Federal Government Targets Small, Mid-sized Practices for Probes of Patient Privacy Violations
7. Cardiac Science signs contract to provide Powerheart AEDs to the state of New Jersey
8. Big Pharma to Come Together at ChemOutsourcing 2013 in Long Branch, New Jersey, Sept 16-19
9. ChemOutsourcing Announces 100 CMO and CRO Exhibitors for September 2013 Show in Long Branch, New Jersey
10. ChemOutsourcing Announces 30 Pharma Company Presenters for September 2013 Outsourcing Show in New Jersey
11. NJBIZ Honors New Jerseys General Counsels
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)...  Pennsylvania Physician General Dr. Rachel Levine ... Gary Tennis released safe prescribing guidelines ... developed with the help of a task force. ... frequently prescribed for anxiety or insomnia," said Dr. ... pain medications, benzodiazepines pose a significant risk for ...
(Date:12/8/2016)... Information products and services provider Elsevier ... Scopus , the world,s largest abstract and citation database of peer-reviewed ... journals from over 5,000 publishers. The new set of metrics will ... and when to adjust a journal,s editorial strategy. ... , , ...
(Date:12/8/2016)... 2016 According to the research report, ... is expected to be worth US$9.7 bn by the ... Between the forecast years of 2016 and 2024, the global ... The leading players operating in the global diabetes injection pens ... plc., Biocon Ltd., and Sanofi S.A. Transparency Market Research reports ...
Breaking Medicine Technology:
(Date:12/8/2016)... ... December 08, 2016 , ... With the increasing demand for dental implants, ... Mouth?” (WIYM) campaign to inform dentists and patients about the safety issues related to ... prosthetic market in the U.S. is projected to reach $6.4 billion in 2018 with ...
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and The ... ultimate weight loss and wellness program, at their world headquarters of Omni La Costa ... and long-term results to anyone seeking weight loss, personal development, a healthy lifestyle, or ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... its innovative Unified Instance Manager architecture, meeting the needs of multichannel growth ... optimizes the unattended auto-dialing system without agents, Presence Robodialer, provides greater operational ...
(Date:12/8/2016)... ... ... STATEN ISLAND, N.Y., Nov. 24, 2016 — Richmond ... of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) services from three ... , Among the recognitions, the American College of Surgeons' (ACS) named the hospital's ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
Breaking Medicine News(10 mins):